These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 3339891)

  • 1. Ischemic myocardial protection. Comparison of nonoxygenated crystalloid, oxygenated crystalloid, and oxygenated fluorocarbon cardioplegic solutions.
    Tabayashi K; McKeown PP; Miyamoto M; Luedtke AE; Thomas R; Allen MD; Misbach GA; Ivey TD
    J Thorac Cardiovasc Surg; 1988 Feb; 95(2):239-46. PubMed ID: 3339891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New pluronic-free perfluorocarbon cardioplegia improves myocardial oxygenation.
    Johnson DL; Greene PS; Gott VL; Gardner TJ
    Circulation; 1988 Nov; 78(5 Pt 2):III153-7. PubMed ID: 3180395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of the hypertrophied pig myocardium. A comparison of crystalloid, blood, and Fluosol-DA cardioplegia during prolonged aortic clamping.
    Novick RJ; Stefaniszyn HJ; Michel RP; Burdon FD; Salerno TA
    J Thorac Cardiovasc Surg; 1985 Apr; 89(4):547-66. PubMed ID: 3157028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oxygenated crystalloid cardioplegia on the functional and metabolic recovery of the isolated perfused rat heart.
    Coetzee A; Kotzé J; Louw J; Lochner A
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):259-69. PubMed ID: 3945093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved myocardial recovery after cardioplegic arrest with an oxygenated crystalloid solution.
    Guyton RA; Dorsey LM; Craver JM; Bone DK; Jones EL; Murphy DA; Hatcher CR
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):877-87. PubMed ID: 3873582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of temperature and hematocrit level of oxygenated cardioplegic solutions on myocardial preservation.
    Rousou JA; Engelman RM; Breyer RH; Otani H; Lemeshow S; Das DK
    J Thorac Cardiovasc Surg; 1988 Apr; 95(4):625-30. PubMed ID: 3352296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of controlled reperfusion after ischemia. XXI. Reperfusate composition: superiority of blood cardioplegia over crystalloid cardioplegia in limiting reperfusion damage--importance of endogenous oxygen free radical scavengers in red blood cells.
    Julia PL; Buckberg GD; Acar C; Partington MT; Sherman MP
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):303-13. PubMed ID: 1992241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved myocardial protection by oxygenation of St. Thomas' Hospital cardioplegic solutions. Studies in the rat.
    Ledingham SJ; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1988 Jan; 95(1):103-11. PubMed ID: 3336223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved myocardial protection with perfluorocarbon cardioplegia.
    Gardner TJ; Flaherty JT; Kanter KR; Magovern GJ
    Prog Clin Biol Res; 1983; 122():405-17. PubMed ID: 6878379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of retrograde cardioplegia. II. Advantages of antegrade/retrograde cardioplegia to optimize distribution in jeopardized myocardium.
    Partington MT; Acar C; Buckberg GD; Julia PL
    J Thorac Cardiovasc Surg; 1989 Apr; 97(4):613-22. PubMed ID: 2927165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
    Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
    J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superiority of perfluorocarbon cardioplegia over blood or crystalloid cardioplegia.
    Kanter KR; Jaffin JH; Ehrlichman RJ; Flaherty JT; Gott VL; Gardner TJ
    Circulation; 1981 Aug; 64(2 Pt 2):II75-80. PubMed ID: 7249332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of amino acids on the ischemic heart. Improvement of oxygenated crystalloid cardioplegic solution by an enriched branched chain amino acid formulation.
    Schwalb H; Izhar U; Yaroslavsky E; Borman JB; Uretzky G
    J Thorac Cardiovasc Surg; 1989 Oct; 98(4):551-6. PubMed ID: 2796362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine instead of supranormal potassium in cardioplegic solution improves cardioprotection.
    Jakobsen Ø; Muller S; Aarsaether E; Steensrud T; Sørlie DG
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):493-500. PubMed ID: 17613242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional and metabolic effects of nicardipine on ischemic rat hearts with multidose potassium cardioplegia].
    Tachibana H
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Apr; 38(4):630-40. PubMed ID: 2373897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of left ventricular venting and distention during heterogenous distribution of cardioplegic solution.
    Lazar HL; Wilcox K; Hankins T; Plehn J; Roberts AJ
    J Thorac Cardiovasc Surg; 1988 Mar; 95(3):501-7. PubMed ID: 3343857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replacing potassium with nicorandil in cold St. Thomas' Hospital cardioplegia improves preservation of energetics and function in pig hearts.
    Steensrud T; Nordhaug D; Husnes KV; Aghajani E; Sørlie DG
    Ann Thorac Surg; 2004 Apr; 77(4):1391-7. PubMed ID: 15063273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of the hypertrophied left ventricle to global ischemia. Comparison of hyperkalemic cardioplegic solution with and without verapamil.
    Huddleston CB; Wareing TH; Boucek RJ; Hammon JW
    J Thorac Cardiovasc Surg; 1992 May; 103(5):919-26. PubMed ID: 1533256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of an oxygen-enriched solution and multiple dosing of antegrade crystalloid cardioplegic solution on myocardial metabolism during coronary artery bypass graft operations.
    Downey RS; Weintraub WS; Jones EL; Conn RB; Ash T
    J Thorac Cardiovasc Surg; 1992 Oct; 104(4):1148-7. PubMed ID: 1405675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.